Double Honor for Prof. Dr. Hans-Georg Rammensee at SITC 2026!
🎉 Congratulations to Prof. Dr. Hans-Georg Rammensee, founding co-spokesperson of the iFIT - Cluster of Excellence, on receiving two prestigious international honors from the Society for Immunotherapy of Cancer (SITC) at its Annual Meeting 2026 in Phoenix, Arizona! Hans-Georg Rammensee has longstanding ties to both the University of Tübingen, where he headed the Department of Immunology at the former Interfaculty Institute of Cell Biology and the Universitätsklinikum Tübingen.
🏅 Hans-Georg Rammensee was honored with the 2027 Richard V. Smalley Memorial Award & Lectureship, recognizing his groundbreaking contributions to cancer immunotherapy. He was also inducted into the 2026 Academy of Immuno-Oncology, which honors internationally renowned pioneers whose scientific discoveries have fundamentally shaped the field.
🔬 His fundamental discoveries in peptide-HLA presentation and T-cell recognition have laid essential foundations for modern cancer immunotherapies, including therapeutic cancer vaccines, T-cell receptor (TCR)-based therapies and bispecific approaches.
💡 As a founding co-spokesperson of iFIT, he played a pivotal role in establishing and shaping the cluster's scientific vision and interdisciplinary approach to cancer research.
🫎The ceremony also brought together Hans-Georg Rammensee and Dr. Harpreet Singh (on the right in the second photo) co-founder of Immatics - one of his former PhD students - accompanied by a very special guest: the moose!
The moose has a long tradition at the Department of Immunology. Its distinctive head and antlers resemble the molecular structure of HLA, inspiring the department's longtime mascot and logo.
🏆 We also warmly congratulate all distinguished scientists inducted into the Academy of Immuno-Oncology in 2026, including Dr. Kristen Hege, Dr. Rachel W. Humphrey, MD, FAIO, and Prof. Dr. John Kirkwood! (from left to right in the first photo)
👏 We are proud to celebrate Hans-Georg Rammensee's outstanding scientific achievements, mentorship and lasting contributions to cancer immunotherapy!
📸 Photo credit: SITC/Thomas Martin